New Cheese-Derived protein powders could make PKU diet easier

NCT ID NCT06941532

Recruiting now Disease control Sponsor: Nutricia UK Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is testing four new powdered protein substitutes made from a milk protein called GMP for people with PKU and tyrosinemia. These conditions require a special low-protein diet, and current formulas can be hard to tolerate. Over 29 days, researchers will check how well 40 adults and children accept the taste, handle digestion, and stick with the new product. The goal is to see if these GMP-based powders are a safe and more pleasant option for daily use.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: GMP-based powdered protein substitute
What this could lead to: If successful, these new protein substitutes could offer a better-tasting, more tolerable option for managing PKU and tyrosinemia, potentially improving diet compliance.
What could go wrong: This is a small, early case series with only 40 participants over 29 days, so results may not apply to everyone. The products may cause gastrointestinal side effects or not be preferred by all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PHENYLKETONURIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

phenylketonuria tyrosinemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHENYLKETONURIA TYROSINEMIA

Contacts and locations

Locations

Birmingham Women and Children's Hospital
RECRUITING

Birmingham, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.